- Home
- CGEN vs ANTA Comparison
CGEN vs ANTA Comparison
Compare CGEN & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGEN | ANTA |
|---|---|---|
| Founded | 1993 | 2022 |
| Country | Israel | Singapore |
| Employees | N/A | 113 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.1M | 182.1M |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | CGEN | ANTA |
|---|---|---|
| Price | $2.02 | $6.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $5.00 | ★ $16.17 |
| AVG Volume (30 Days) | ★ 440.2K | 2.2K |
| Earning Date | 05-18-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $21.95 |
| Revenue Next Year | $75.09 | $30.46 |
| P/E Ratio | ★ N/A | $19.77 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.30 | $6.00 |
| 52 Week High | $3.24 | $13.82 |
Technical Indicators
Market Signals| Indicator | CGEN | ANTA |
|---|---|---|
| Relative Strength Index (RSI) | 35.96 | 34.72 |
| Support Level | $1.98 | N/A |
| Resistance Level | $2.35 | $9.81 |
| Average True Range (ATR) | 0.10 | 0.41 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 20.97 | 8.93 |
Price Performance
Historical ComparisonAbout CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
About ANTA Antalpha Platform Holding Company Ordinary Shares
Antalpha Platform Holding Co provides financing, technology and risk management solutions to institutional and corporate customers in the crypto asset industry. The company operates through Antalpha Prime platform in the following areas: Supply chain financing and Technology and services. Its revenue prominently consists of technology financing fees charged on the supply chain loans.